NCT06419660View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 22, 2024

Primary Completion Date

July 8, 2024

Study Completion Date

July 8, 2024

Conditions
Healthy
Interventions
DRUG

BI 300202

BI 300202

DRUG

esomeprazole

esomeprazole

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06419660 - A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood | Biotech Hunter | Biotech Hunter